Aging begins at the cellular level, and TROIL's core intervention technology targets the root causes of aging. Unlike conventional methods, TROIL relies on an advanced AI-powered pharmaceutical ...
日前，第75届美国肝病研究学会（AASLD）年会暨2024年肝脏大会（The Liver Meeting, TLM）在美国加利福尼亚州圣迭戈开幕。此次大会吸引了来自全球96个国家的近9000名肝病领域的专家学者，重点聚焦非酒精性脂肪性肝病（NAFLD）这一公卫危机。
在这一严峻背景下，美国高端健康品牌TROIL特瑞益，凭借其在健康领域的深厚科研底蕴及创新性专利技术，推出了心血管健康管理制剂——“益血心”。
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback